Futura Medical (FUM) RNS Announcements

Add to Alert list
Date Time Source Announcement
27 Sep 2004 07:00 AM
RNS
Interim Results
21 Sep 2004 12:46 PM
RNS
Notice of Results-Correction
21 Sep 2004 08:00 AM
RNS
Appointment of joint broker
20 Sep 2004 07:00 AM
RNS
Notice of Results
24 Aug 2004 02:03 PM
RNS
Holding in Company
21 Jul 2004 02:39 PM
RNS
Additional Listing
21 Jul 2004 10:19 AM
RNS
Additional Listing
12 Jul 2004 07:00 AM
RNS
Reformulation of treatment
01 Jul 2004 05:55 PM
RNS
Sale of royalty rights
15 Jun 2004 11:29 AM
RNS
Holding in Company
26 May 2004 07:00 AM
RNS
Results of clinical trial
21 Apr 2004 07:00 AM
RNS
Non-exercise of option
21 Apr 2004 07:00 AM
RNS
Result of pilot med. trial
15 Apr 2004 12:07 PM
RNS
Holding in Company
05 Apr 2004 11:40 AM
RNS
Holding in Company
08 Mar 2004 07:00 AM
RNS
Issue of Equity
23 Feb 2004 03:40 PM
RNS
Additional Listing
23 Feb 2004 11:53 AM
RNS
Final Results-Replacement
23 Feb 2004 07:00 AM
RNS
Progress in concept study
23 Feb 2004 07:00 AM
RNS
Final Results
20 Feb 2004 12:11 PM
RNS
Holding(s) in Company
18 Feb 2004 10:28 AM
RNS
Holding(s) in Company
17 Feb 2004 11:04 AM
RNS
Additional Listing
16 Feb 2004 03:49 PM
RNS
Additional Listing
13 Feb 2004 05:07 PM
RNS
Holding(s) in Company
09 Feb 2004 05:26 PM
RNS
Additional Listing
05 Feb 2004 07:00 AM
RNS
Exercising second call option
19 Jan 2004 10:19 AM
RNS
Re Agreement
05 Dec 2003 07:00 AM
RNS
DTI Grant Awarded
28 Nov 2003 07:00 AM
RNS
Announcement of Fundraising
22 Sep 2003 07:00 AM
RNS
Interim Results
15 Sep 2003 12:17 PM
RNS
Notice of Results
02 Sep 2003 02:28 PM
RNS
Holding(s) in Company
22 Jul 2003 08:11 AM
RNS
Admission to AIM

Futura Medical is the developer of innovative sexual health products, including lead product Eroxon®. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

FUM share price listed on AIM in 2003.

UK 100

Latest directors dealings